Justin Stebbing

机构：Hammersmith Hospital, Imperial College London, Anglia Ruskin University · ORCID：0000-0002-1117-6947

发表论文 1073 篇 · 总被引 31626 次 · h-index 84

代表论文

• Botensilimab (Fc-enhanced anti–CTLA-4 antibody) plus balstilimab (anti–PD-1 antibody) in patients with treatment-refractory ovarian cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 4)
• Clinical validity of repeated circulating tumor cell enumeration as an early treatment monitoring tool for metastatic breast cancer in the PREDICT global pooled analysis. (2026 · UNC Libraries)
• Biomarker Testing in Advanced Non–Small Cell Lung Cancer: Time Is of the Essence (2026 · JCO Oncology Practice)
• The HPV vaccine works – but only if we keep trusting it (2026)
• Supplementary Table S8 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy (2026)
• Supplementary Figure S11 from Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy (2026)